Literature DB >> 9933660

Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study.

R R Raylman1, P V Kison, R L Wahl.   

Abstract

The capabilities and limitations of two-(2D) and three-dimensional (3D) fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) in detecting small tumors and lymph nodes were studied in a phantom modeling the human chest and axilla. Multiple dual-radionuclide phantom studies were performed. Five hollow spheres ranging in diameter from 3 mm to 15 mm were filled with carbon-11 and placed in the axillary and mediastinal regions of an anthropomorphic phantom containing hollow organs filled with 18F to simulate FDG uptake 1 h after injection. Dynamic imaging was performed to acquire PET images with varying target-to-background ratios. Imaging was performed in 2D and 3D acquisition modes, with and without attenuation correction, on a modern PET scanner. Lesion detectability was visually and quantitatively assessed. For objects larger than 9 mm in diameter, target-to-background ratios ranging from approximately 3:1 to approximately 10:1 were detectable. Objects < 9 mm in diameter required a target-to-background ratio of >/=18:1. Target-to-background ratios required for lesion detectability were equivalent for 2D and 3D PET images with and without attenuation correction. In conclusion, 2D and 3D PET with attenuation correction consistently detected "tumors" >/= 9 mm. Lesions < 9 mm could be detected if there was high enough tumor uptake. No statistically significant differences in lesion detection were found for 2D versus 3D PET, or for attenuation-corrected versus non-attenuation-corrected images.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933660     DOI: 10.1007/s002590050357

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  Count-Rate Performance of the Discovery STE PET Scanner Using Partial Collimation.

Authors:  Lawrence R Macdonald; Ruth E Schmitz; Adam M Alessio; Scott D Wollenweber; Charles W Stearns; Alexander Ganin; Robert L Harrison; Thomas K Lewellen; Paul E Kinahan
Journal:  IEEE Nucl Sci Symp Conf Rec (1997)       Date:  2006

3.  Optimization of noise equivalent count rate performance for a partially collimated PET scanner by varying the number of septa.

Authors:  Ruth E Schmitz; Robert L Harrison; Charles W Stearns; Thomas K Lewellen; Paul E Kinahan
Journal:  IEEE Trans Med Imaging       Date:  2007-07       Impact factor: 10.048

4.  Measured count-rate performance of the Discovery STE PET/CT scanner in 2D, 3D and partial collimation acquisition modes.

Authors:  L R Macdonald; R E Schmitz; A M Alessio; S D Wollenweber; C W Stearns; A Ganin; R L Harrison; T K Lewellen; P E Kinahan
Journal:  Phys Med Biol       Date:  2008-06-23       Impact factor: 3.609

5.  Optimization of injection dose based on noise-equivalent count rate with use of an anthropomorphic pelvis phantom in three-dimensional 18F-FDG PET/CT.

Authors:  Kazumasa Inoue; Hideo Kurosawa; Takashi Tanaka; Masahiro Fukushi; Noriyuki Moriyama; Hirofumi Fujii
Journal:  Radiol Phys Technol       Date:  2011-12-30

6.  Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.

Authors:  D Visvikis; D Griffiths; D C Costa; J Bomanji; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-22       Impact factor: 9.236

7.  PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.

Authors:  Michael J Reinhardt; Nicole Wiethoelter; Alexander Matthies; Alexius Y Joe; Holger Strunk; Ursula Jaeger; Hans-Juergen Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

8.  Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.

Authors:  Ertan Şahin; Ahmet Kara; Umut Elboğa
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

9.  Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.

Authors:  Yuka Yamamoto; Yoshihiro Nishiyama; Shinya Ishikawa; Jun Nakano; Sung Soo Chang; Shuji Bandoh; Nobuhiro Kanaji; Reiji Haba; Yoshio Kushida; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

10.  Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer.

Authors:  Yuka Yamamoto; Yoshihiro Nishiyama; Naruhide Kimura; Shinya Ishikawa; Masaya Okuda; Shuji Bandoh; Nobuhiro Kanaji; Masato Asakura; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.